Literature DB >> 10725746

Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.

S Shahabuddin1, P Ponath, R P Schleimer.   

Abstract

Eosinophils are the predominant cell type recruited in inflammatory reactions in response to allergen challenge. The mechanisms of selective eosinophil recruitment in allergic reactions are not fully elucidated. In this study, the ability of several C-C chemokines to induce transendothelial migration (TEM) of eosinophils in vitro was assessed. Eotaxin, eotaxin-2, monocyte chemotactic protein (MCP)-4, and RANTES induced eosinophil TEM across unstimulated human umbilical vein endothelial cells (HUVEC) in a concentration-dependent manner with the following rank order of potency: eotaxin approximately eotaxin-2 > MCP-4 approximately RANTES. The maximal response induced by eotaxin or eotaxin-2 exceeded that of RANTES or MCP-4. Preincubation of eosinophils with anti-CCR3 Ab (7B11) completely blocked eosinophil TEM induced by eotaxin, MCP-4, and RANTES. Activation of endothelial cells with IL-1beta or TNF-alpha induced concentration-dependent migration of eosinophils, which was enhanced synergistically in the presence of eotaxin and RANTES. Anti-CCR3 also inhibited eotaxin-induced eosinophil TEM across TNF-alpha-stimulated HUVEC. The ability of eosinophil-active cytokines to potentiate eosinophil TEM was assessed by investigating eotaxin or RANTES-induced eosinophil TEM across resting and IL-1beta-stimulated HUVEC in the presence or absence of IL-5. The results showed synergy between IL-5 and the chemokines but not between IL-5 and the endothelial activator IL-1beta. Our data suggest that eotaxin, eotaxin-2, MCP-4, and RANTES induce eosinophil TEM via CCR3 with varied potency and efficacy. Activation of HUVEC by IL-1beta or TNF-alpha or priming of eosinophils by IL-5 both promote CCR3-dependent migration of eosinophils from the vasculature in conjunction with CCR3-active chemokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725746     DOI: 10.4049/jimmunol.164.7.3847

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.

Authors:  K Jovanovic; M Siebeck; R Gropp
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

2.  Eosinophils utilize multiple chemokine receptors for chemotaxis to the parasitic nematode Strongyloides stercoralis.

Authors:  Louis H Stein; Kevin M Redding; James J Lee; Thomas J Nolan; Gerhard A Schad; James B Lok; David Abraham
Journal:  J Innate Immun       Date:  2009-08-05       Impact factor: 7.349

Review 3.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 4.  Eosinophil function in allergic inflammation: from bone marrow to tissue response.

Authors:  Darryl Adamko; Paige Lacy; Redwan Moqbel
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

5.  CCL24 Signaling in the Tumor Microenvironment.

Authors:  Sung-Jig Lim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection.

Authors:  Karen Smith Korsholm; Rune V Petersen; Else Marie Agger; Peter Andersen
Journal:  Immunology       Date:  2009-07-14       Impact factor: 7.397

7.  Functional effects of eotaxin are selectively upregulated on IL-5 transgenic mouse eosinophils.

Authors:  Elizabeth Kudlacz; Carrie Whitney; Catharine Andresenl; Maryrose Conklyn
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

Review 8.  Mechanisms of eosinophil recruitment and activation.

Authors:  Darryl Adamko; Paige Lacy; Redwan Moqbel
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.919

9.  Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.

Authors:  Aikaterini Detoraki; Eugenio Tremante; Remo Poto; Emanuela Morelli; Giuseppe Quaremba; Francescopaolo Granata; Antonio Romano; Ilaria Mormile; Francesca Wanda Rossi; Amato de Paulis; Giuseppe Spadaro
Journal:  Respir Res       Date:  2021-06-23

10.  Topical application of herbal mixture extract inhibits ovalbumin- or 2,4-dinitrochlorobenzene-induced atopic dermatitis.

Authors:  Soon Re Kim; Han-Seok Choi; Hye Sook Seo; Youn Kyung Choi; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.